Abstract
With the proteasome emerging as a therapeutic target for cancer treatment, accurate tools for monitoring proteasome (inhibitor) activity are in demand. In this chapter, we describe the synthesis and use of a fluorescent proteasome activity probe that allows for accurate profiling of proteasomal activity in cell lysates, intact cells, and murine and human patient-derived material, with high sensitivity using SDS-PAGE. The probe allows for direct scanning of the gel for fluorescent emission of the distinct proteasomal subunits and circumvents the use of Western blot analysis. Due to its suitable biochemical and biophysical properties, the fluorescent probe can also be used for confocal laser scanning microscopy and flow cytometry-based experiments.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Richardson, P. G., Mitsiades, C., Hideshima, T., and Anderson, K. C. (2006) Bortezomib: proteasome inhibition as an effective anticancer therapy. Annu. Rev. Med 57 33–47.
Etlinger, J. D. and Goldberg, A. L. (1977) A soluble ATP-dependent proteolytic system responsible for the degradation of abnormal proteins in reticulocytes. Proc. Natl Acad. Sci. USA 74 54–58.
Glickman, M. H. and Ciechanover, A. (2002) The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev. 82 373–428.
Concannon, C. G., Koehler, B. F., Reimertz, C., Murphy, B. M., Bonner, C., Thurow, N. et al. (2007) Apoptosis induced by proteasome inhibition in cancer cells: predominant role of the p53/PUMA pathway. Oncogene 26 1681–1692.
Hideshima, T., Richardson, P., Chauhan, D., Palombella, V. J., Elliott, P. J., Adams, J. et al. (2001) The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res 61 3071–3076.
Kane, R. C., Bross, P. F., Farrell, A. T., and Pazdur, R. (2003) Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy. Oncologist 8 508–513.
Kane, R. C., Dagher, R., Farrell, A., Ko, C. W., Sridhara, R., Justice, R. et al. (2007) Bortezomib for the treatment of mantle cell lymphoma. Clin Cancer Res 13 5291–5294.
Stohwasser, R., Standera, S., Peters, I., Kloetzel, P. M., and Groettrup, M. (1997) Molecular cloning of the mouse proteasome subunits MC14 and MECL-1: reciprocally regulated tissue expression of interferon-gamma-modulated proteasome subunits. Eur J Immunol. 27 1182–1187.
Dahlmann, B., Ruppert, T., Kuehn, L., Merforth, S., and Kloetzel, P. M. (2000) Different proteasome subtypes in a single tissue exhibit different enzymatic properties. J Mol Biol 303 643–653.
Dahlmann, B., Ruppert, T., Kloetzel, P. M., and Kuehn, L. (2001) Subtypes of 20S proteasomes from skeletal muscle. Biochimie 83 295–299.
Elliott, P. J., Soucy, T. A., Pien, C. S., Adams, J., and Lightcap, E. S. (2003) Assays for proteasome inhibition. Methods Mol Med 85 163–172.
Lightcap, E. S., McCormack, T. A., Pien, C. S., Chau, V., Adams, J., and Elliott, P. J. (2000) Proteasome inhibition measurements: clinical application. Clin Chem 46 673–683.
Berkers, C. R., Verdoes, M., Lichtman, E., Fiebiger, E., Kessler, B. M., Anderson, K. C. et al. (2005) Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib. Nat. Methods 2 357–362.
Berkers, C. R., van Leeuwen, F. W., Groothuis, T. A., Peperzak, V., van Tilburg, E. W., Borst, J. et al. (2007) Profiling proteasome activity in tissue with fluorescent probes. Mol Pharm. 4 739–748.
Bogyo, M., Shin, S., McMaster, J. S., and Ploegh, H. L. (1998) Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes. Chem Biol 5 307–320.
Kessler, B. M., Tortorella, D., Altun, M., Kisselev, A. F., Fiebiger, E., Hekking, B. G. et al. (2001) Extended peptide-based inhibitors efficiently target the proteasome and reveal overlapping specificities of the catalytic beta-subunits. Chem Biol 8 913–929.
Ovaa, H., van Swieten, P. F., Kessler, B. M., Leeuwenburgh, M. A., Fiebiger, E., van den Nieuwendijk, A. M. et al. (2003) Chemistry in living cells: detection of active proteasomes by a two-step labeling strategy. Angew Chem Int Ed Engl 42 3626–3629.
Verdoes, M., Florea, B. I., Menendez-Benito, V., Maynard, C. J., Witte, M. D., van der Linden, W. A. et al. (2006) A fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in vitro and in vivo. Chem Biol 13 1217–1226.
Dantuma, N. P., Lindsten, K., Glas, R., Jellne, M., and Masucci, M. G. (2000) Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells. Nat Biotechnol 18 538–543.
Lindsten, K., Menendez-Benito, V., Masucci, M. G., and Dantuma, N. P. (2003) A transgenic mouse model of the ubiquitin/proteasome system. Nat Biotechnol 21 897–902.
Luker, G. D., Pica, C. M., Song, J., Luker, K. E., and Piwnica-Worms, D. (2003) Imaging 26S proteasome activity and inhibition in living mice. Nat Med 9 969–973.
Bogyo, M., McMaster, J. S., Gaczynska, M., Tortorella, D., Goldberg, A. L., and Ploegh, H. (1997) Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors. Proc Natl Acad Sci USA 94 6629–6634.
Smith, K. M. and Pandey, R. K. (1983) New Efficient Total Syntheses of Derivatives of Protoporphyrin-IX Bearing Deuturated Methyl Groups. 20 1383–1388.
Still, W. C., Kahn, M., and Mitra, A. (1978) Rapid Chromatographic Technique for Preparative Separations with Moderate Resolution. Journal of Organic Chemistry 43 2923–2925.
Palmer, J. T., Rasnick, D., Klaus, J. L., and Bromme, D. (1995) Vinyl sulfones as mechanism-based cysteine protease inhibitors. J Med Chem 38 3193–3196.
Rydzewski, R., Burrill, L., Mendonca, R., Palmer, J., Rice, M., Tahilramani, R. et al. (2006) Optimization of Subsite Binding to the 5 Subunit of the Human 20S Proteasome Using Vinyl Sulfones and 2-Keto-1,3,4-oxadiazoles: Syntheses and Cellular Properties of Potent, Selective Proteasome Inhibitors. Journal of Medicinal Chemistry 49 2953–2968.
Wang, G., Mahesh, U., Chen, G. Y., and Yao, S. Q. (2003) Solid-phase synthesis of peptide vinyl sulfones as potential inhibitors and activity-based probes of cysteine proteases. Org Lett 5 737–740.
Acknowledgements
Henk Hilkmann is acknowledged for peptide synthesis and the authors thank Dr Kees Jalink for assistance with fluorescence spectroscopy. C.R.B. is supported by KWF grant 2005-3368.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
de Jong, A., Schuurman, K.G., Rodenko, B., Ovaa, H., Berkers, C.R. (2012). Fluorescence-Based Proteasome Activity Profiling. In: Drewes, G., Bantscheff, M. (eds) Chemical Proteomics. Methods in Molecular Biology, vol 803. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-364-6_13
Download citation
DOI: https://doi.org/10.1007/978-1-61779-364-6_13
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-363-9
Online ISBN: 978-1-61779-364-6
eBook Packages: Springer Protocols